Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in number of shares and votes in Ascelia Pharma AB (publ)

During April, the registered number of shares and votes in Ascelia Pharma AB (publ) has increased due to the new issue that was executed in connection with the exercise of the over-allotment option subsequent to the listing of the company’s shares on Nasdaq Stockholm. As of 30 April 2019, the registered number of shares and votes in Ascelia Pharma AB (publ) amounts to 23,488,908.For more information, please contactMagnus Corfitzen, CEOEmail: moc@ascelia.comTel: +46 735 179 110 Mikael Widell, IR & Communications ManagerEmail: mw@ascelia.comTel: +46 703 11 99 60This information

Q1 report 2019: Visma continues expansion in the Netherlands and reaches NOK 10 billion in cloud annualised revenue

Revenues in Visma's three largest divisions continued high, with double-digit growth year-on-year. The SMB Division grew revenues by 17 percent, Enterprise grew by an impressive 78 percent and Custom Solutions achieved 48 percent growth compared to the first quarter last year. SaaS and SaaS transactions continue to be the strongest drivers of organic growth in Visma, and cloud annualised revenue grew by 57 percent to reach NOK 10,100 million. Download the full report  Growth in e-invoicing

Orkla ASA: Issuance of Commercial Paper

Orkla ASA has issued a commercial paper of NOK 500,000,000. Start date:                   6 May 2019Maturity:                     8 July 2019Coupon:                      1.33 %Organised by:             DNB Markets Orkla ASAOslo, 30 April 2019 Ref.: Senior Vice President Group TreasuryGeir SolliTel.: +47 995 42 789 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Peab signs new blanket contract with federal Specialfastigheter

Peab has signed a nationwide blanket contract that covers construction contract work in major new construction, renovation and extension projects for federal Specialfastigheter.Peab is thereby one of a few select construction companies to sign a contract. It covers construction projects worth more than SEK 100 million within Specialfastigheters’ existing property stock and any new establishments in Sweden. It runs for seven years. Peab already has a contract with Specialfastigheter for smaller construction projects. Security has top priority in federal Specialfastigheter with buildings

Orkla's acquisition of Easyfood A/S completed

In its press release of 21 December 2018, Orkla announced that it had entered into an agreement to purchase 90 per cent of the shares in Easyfood A/S, a Danish producer of bread-based convenience products for the out-of-home channel. The transaction has been approved by relevant competition authorities, and was completed today. The company will be consolidated into Orkla's financial statements as from 1 May 2019. Please find enclosed the press release issued 21 December 2018. Orkla is a leading supplier of branded consumer goods and concept solutions to the consumer, out-of-home

Lehto Group Plc: Lehto sells a portfolio of 542 apartments

Lehto Group PlcInsider information30 April 2019 at 2.45 p.m.Lehto Asunnot Oy (“Lehto”), a fully owned subsidiary of Lehto Group Plc, has today signed an agreement with DWS, on behalf of one of its residential real estate funds to build and sell a residential property portfolio consisting of 542 apartments to DWS. The portfolio consists of six different buildings located in the cities of Espoo, Turku, Kirkkonummi, Riihimäki and Jyväskylä in Finland. Some of the buildings are already under construction and all buildings will be completed during the years 2019-2020. According to the

Correction: Elkem ASA – Minutes from the annual general meeting 2019

Oslo, 30 April 2019. Reference is made to the stock exchange notice dated 30 April 2019 in relation to minutes from the annual general meeting 2019. The correct date for the share to be traded ex-dividend is from 2 May 2019. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information, please contact: Odd-Geir Lyngstad, VP Finance & Investor Relations Tel: +47 976 72 806 Email: odd-geir.lyngstad@elkem.no About Elkem ASAFounded in 1904, Elkem is one of the world's leading

Invent Medic’s product Efemia Bladder Support improved quality of life significantly in follow-up study

Invent Medic’s innovative medical technology product Efemia Bladder Support was shown to significantly improve quality of life for 75% of the participants in a follow-up study with women that participated in the company’s clinical study.The follow-up study was conducted to improve the knowledge on how Efemia effects self-reported quality of life in women with clinically diagnosed stress urinary incontinence. 40 women were invited to participate in the study. Of these, 28 accepted and completed the whole study. Professor Aino Fianu Jonasson, specialist in urogynecology at the Karolinska

Young Swedish talents nominated at Cannes Film Festival

Stockholm International Film Festival celebrates the news that Swedish directors Elin Övergaard and Levan Akin will be competing at this year's Cannes Film Festival. Both talents started their careers at the Stockholm Film Festival, an important platform for young aspiring filmmakers in Sweden.Swedish talent Elin Övergaard and her short film ”Ingen lyssnar” ("Who Talks") is nominated for the prestigious short film award at the Cannes Film Festival. Elin started her career as a filmmaker at an early age. She was only 12 years old when she won the short film competition for youngsters at

UPM-Kymmene Corporation: Managers' Transactions (Oudeman)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Oudeman) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 1,685 shares has been purchased to Marjan Oudeman as follows: Person subject to the

Half-year report

First Half (2018-09-01 till 2018-02-28) · Operating income amounted to SEK 508,7795 (391,204). · Operating result amounted to SEK -8,929,084 (-7,524,256).                         · Earnings per share* amounted to SEK -0.83 (-0.88). · Cash and bank amounted to SEK 6,886,879 (9,444,381). · Solidity** amounted to 87 (59) %. **Result per share: operating results divided by the average number of shares. Average number of shares for the first half of 2018/2019: 11,486,456 shares (8,505,425). Number of shares in NextCell as per February 28th, 11,486,456 shares(8,505,425). *

Revenio completes CenterVue acquisition

Stock exchange release, 30 April, 2019 at 14.30 EETRevenio completes CenterVue acquisition Revenio Group Corporation ("Revenio", "the Company") has today completed the acquisition disclosed on 13 April 2019 of the entire share capital of the Italian CenterVue SpA (“CenterVue”) at an enterprise value of EUR 59 million. The purchase price was paid in cash. In addition, the parties have agreed on an arrangement whereby Revenio will pay an additional purchase price of EUR 1 million upon the fulfillment of the terms of the additional purchase price, agreed on by the parties, by the end of

UPM-Kymmene Corporation: Managers' Transactions (Ehrnrooth)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Ehrnrooth) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 1,685 shares has been purchased to Henrik Ehrnrooth as follows: Person subject to the

UPM-Kymmene Corporation: Managers' Transactions (Puheloinen)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Puheloinen) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 1,685 shares has been purchased to Ari Puheloinen as follows: Person subject to the

UPM-Kymmene Corporation: Managers' Transactions (Wahlroos)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Wahlroos) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 2,911 shares has been purchased to Björn Wahlroos as follows: Person subject to the

UPM-Kymmene Corporation: Managers' Transactions (Brunow)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Brunow) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 2,068 shares has been purchased to Berndt Brunow as follows: Person subject to the

UPM-Kymmene Corporation: Managers' Transactions (Kauppi)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Kauppi) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 1,685 shares has been purchased to Piia-Noora Kauppi as follows: Person subject to the

UPM-Kymmene Corporation: Managers' Transactions (Reinikkala)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Reinikkala) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 1,685 shares has been purchased to Veli-Matti Reinikkala as follows: Person subject to

UPM-Kymmene Corporation: Managers' Transactions (Wahl)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Wahl) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 1,685 shares has been purchased to Kim Wahl as follows: Person subject to the notification

UPM-Kymmene Corporation: Managers' Transactions (Thoma)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Thoma) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 1,685 shares has been purchased to Suzanne Thoma as follows: Person subject to the

UPM-Kymmene Corporation: Managers' Transactions (Oudeman)

UPM-Kymmene Corporation      Managers' Transactions         30 April 2019 at 14:30 EET UPM-Kymmene Corporation: Managers' Transactions (Oudeman) On 4 April 2019, the Annual General Meeting of UPM-Kymmene Corporation resolved that the annual base fee of the company's Board of Directors is paid in the company shares and cash so that approximately 40% is payable in the company shares to be purchased on the Board members' behalf, and the rest in cash. In accordance with this resolution, a total of 1,685 shares has been purchased to Marjan Oudeman as follows: Person subject to the

There are no items matching the current filter
There are no more items matching the current filter
Back to top